After obtaining Class B medical device registration under MDACS (Medical Device Administrative Control System) in Hong Kong, there are several key post-listing obligations and considerations you should be aware of to ensure continued compliance:
Validity: Device listing under MDACS does not expire, but must be maintained.
The Local Responsible Person (LRP) must notify the Medical Device Division (MDD) of:
Changes in manufacturer, device model, or classification
Changes to labeling, Instructions for Use (IFU), or packaging
Regulatory status changes (e.g., CE mark withdrawn)
📌 Use Form MD5 (Notification of Changes) to report updates.
Although MDACS is voluntary, the LRP is expected to monitor safety and report incidents:
Adverse events or field safety corrective actions (FSCA) must be reported to MDD.
Report using Form MD7.
📌 Refer to Guidance Note GN-10 for PMS obligations.
All devices sold or distributed in Hong Kong must carry:
Correct labeling (English or Chinese)
Listing number (if issued)
Manufacturer details, model, lot/serial number, expiry date
📌 Continue to comply with GN-03 – Labelling Requirements.
The LRP must maintain records of:
Sales and distribution
Complaints and recalls
Correspondence with regulatory bodies
Retention period: 5 years after last date of manufacture or supply.
Ensure all promotional materials (brochures, websites, packaging) are:
Accurate, not misleading
Consistent with the intended use and claims submitted during registration
Although MDACS is voluntary, MDD may conduct spot checks or request documentation at any time.
Be prepared to provide:
Updated QMS certificates
Technical documentation
Traceability records
If you intend to stop supplying the device in Hong Kong:
Submit Form MD6 to voluntarily delist the device.
Remove the listing number from packaging and marketing materials.
Ensure your reference market certificate (e.g. CE, FDA, TGA) remains valid.
If revoked or expired, MDACS listing must be updated or reconsidered.
Regularly check the MDD website for:
Updated guidance notes
Changes in submission procedures or regulatory policy
.jpg)
Whatsapp or Wechat:+86 15816864648;email address:hito.lin@grzan.cn